Wasserman J - Search Results

1

Immunological changes in primary HIV-1 infection.

Gaines H, von Sydow MA, von Stedingk LV, Biberfeld G, Böttiger B, Hansson LO, Lundbergh P, Sönnerborg AB, Wasserman J, Strannegåard OO. Gaines H, et al. Among authors: wasserman j. AIDS. 1990 Oct;4(10):995-9. doi: 10.1097/00002030-199010000-00008. AIDS. 1990. PMID: 2261128

2

Blood lymphocyte population following 131I treatment for hyperthyroidism.

Blomgren H, Wasserman J, Petrini B, von Stedingk LV. Blomgren H, et al. Among authors: wasserman j. Acta Endocrinol (Copenh). 1991 Feb;124(2):152-8. doi: 10.1530/acta.0.1240152. Acta Endocrinol (Copenh). 1991. PMID: 1825898

3

Changes of the blood lymphocyte subpopulations and their functions following 131I treatment for nodular goitre and 32P treatment for polycythemia vera.

Wasserman J, Blomgren H, Petrini B, Svedmyr E, Schnell PO, Lundell G, Von Stedingk LV. Wasserman J, et al. Int J Radiat Biol Relat Stud Phys Chem Med. 1988 Jan;53(1):159-67. doi: 10.1080/09553008814550511. Int J Radiat Biol Relat Stud Phys Chem Med. 1988. PMID: 3257474

4

Changes of the blood lymphocyte population following 32P treatment for polycythemia vera.

Blomgren H, Petrini B, Wasserman J, von Stedingk LV, Svedmyr E. Blomgren H, et al. Among authors: wasserman j. Eur J Haematol. 1990 May;44(5):302-6. doi: 10.1111/j.1600-0609.1990.tb00399.x. Eur J Haematol. 1990. PMID: 2369942

5

Impact of adjuvant chemotherapy on spontaneous and poke week mitogen triggered immunoglobulin secretion of blood lymphocytes in operable breast cancer.

Blomgren H, Wasserman J, Rotstein S, Petrini B, von Stedingk LV. Blomgren H, et al. Among authors: wasserman j. Anticancer Res. 1988 Jul-Aug;8(4):839-44. Anticancer Res. 1988. PMID: 3178174

6

Influence of adjuvant tamoxifen on blood lymphocytes.

Rotstein S, Blomgren H, Petrini B, Wasserman J, von Stedingk LV. Rotstein S, et al. Among authors: wasserman j. Breast Cancer Res Treat. 1988 Sep;12(1):75-9. doi: 10.1007/BF01805743. Breast Cancer Res Treat. 1988. PMID: 3196888 Clinical Trial.

7

Elevated serum beta-2-microglobulin--a prognostic marker for development of AIDS among patients with persistent generalized lymphadenopathy.

Morfeldt-Månson J, Julander I, von Stedingk LV, Wasserman J, Nilsson B. Morfeldt-Månson J, et al. Among authors: wasserman j. Infection. 1988 Mar-Apr;16(2):109-10. doi: 10.1007/BF01644315. Infection. 1988. PMID: 3286507

8

Beta-2-microglobulin serum levels in patients with HIV-infections.

Julander I, Von Stedingk L, Moberg L, Morfeldt-Månsson L, Wasserman J. Julander I, et al. Among authors: wasserman j. Chemioterapia. 1987 Jun;6(2 Suppl):638. Chemioterapia. 1987. PMID: 3334655 No abstract available.

9

Influence of interferon on antibody production and viability of malignant cells from patients with multiple myeloma.

Grandér D, von Stedingk LV, von Stedingk M, Wasserman J, Einhorn S. Grandér D, et al. Among authors: wasserman j. Eur J Haematol. 1991 Jan;46(1):17-25. doi: 10.1111/j.1600-0609.1991.tb00508.x. Eur J Haematol. 1991. PMID: 1703088

10

Persistent generalized lymphadenopathy: immunological and mycological investigations.

Torssander J, Wasserman J, Morfeldt-Månsson L, Petrini B, von Stedingk LV. Torssander J, et al. Among authors: wasserman j. Acta Derm Venereol. 1985;65(6):515-20. Acta Derm Venereol. 1985. PMID: 2420116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

595 results

Search Page

Filters